C-luminary Biotechnology Co., Ltd. is a biotechnology startup based in China, founded in 2018. The company's slogan is to provide one-stop CLIA solutions. They specialize in offering chemiluminescent immunoassay (CLIA) solutions, with a focus on autoimmune & allergy disease diagnostics. Their services are tailored to assist IVD companies in serving hospitals and clinical laboratories effectively. The startup received a significant boost with a CNY100.00M Series B investment on 19 July 2023, with funding from Yuanbio VC and Bencao Capital. This latest investment is a testament to the potential and promise that C-luminary Biotechnology Co., Ltd. holds in the health care industry.
No recent news or press coverage available for C-luminary Biotechnology Co., Ltd..